Company Profile

Nanofiber Solutions LLC
Profile last edited on: 4/30/18      CAGE: 5GDZ1      UEI: NFE9VKF3CLH5

Business Identifier: 3D nanofiber technologies for regenerative medicine, veterinary and cell cultures
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1275 Kinnear Road
Columbus, OH 43212
   (614) 559-9065
Location: Single
Congr. District: 15
County: Franklin

Public Profile

Nanofiber Solutions, LLC manufactures 3D nanofiber technologies for cell culture, cancer research, and stem cell expansion applications. Its aligned nanofiber scaffolds technology platform provides researchers with biologically realistic cell culture leading to enhanced biomedical research and stem cell expansion, as well as market for drug development. The company sells various cell culture products, including well plates, larger dishes, and custom manufactured scaffolds for large bioreactors and in vivo tissue engineering applications. Its products facilitate tests that involve cell migration/invasion, drug discovery, stem cell expansion and directed differentiation, and in vitro diagnostics; offer a 3D topography that mimics the in vivo topography; are optically transparent to allow live-cell imaging and real time quantification of cell mobility; have the same general size and shape of standard cell culture dishes allowing ease of acceptance and compatibility with automated systems and current equipment. The company was founded in 2009 and is based in Columbus, Ohio.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 AF $50,000
Project Title: Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
2019 1 NIH $224,999
Project Title: Synthetic Resorbable AV Graft
2018 1 NIH $225,000
Project Title: Off-The-Shelf Patch for Repairing Tracheal Stenosis
2018 2 NIH $1,640,355
Project Title: Tissue Engineered Intestine
2017 2 NSF $870,634
Project Title: Development of a Tissue Engineered Trachea

Key People / Management

  Ross Kayuha -- Chief Executive Officer

  Jed K Johnson -- Co-founder, CTO

  John Lannutti -- co-founder